Skip to content
Pharma
Bioequivalence Studies
Pharmaceutical Equivalence
Analytical Services
Development and validation of assays for content,
impurities and residual solvents
Solubility and dissolution for R&D
Stability study (physicochemical analysis)
Forced degradation (compliance with RDC 53/2015)
Extractables and leachables study (analysis)
Elemental impurities USP-NF <232>/<233> and ICH Q3D
Nitrosamines Study (Phase 2)
Clinical Research Center Phase I to IV
CRO Services
Regulatory Affairs
Medical Writing
Management of Phase I to IV Studies
Clinical Monitoring
Biostatistics
Central Laboratory
Toxicology
Diagnostics
Software
About Us
Who We Are
Our Structure
Careers
Blog
Pharma
Bioequivalence Studies
Pharmaceutical Equivalence
Analytical Services
Development and validation of assays for content,
impurities and residual solvents
Solubility and dissolution for R&D
Stability study (physicochemical analysis)
Forced degradation (compliance with RDC 53/2015)
Extractables and leachables study (analysis)
Elemental impurities USP-NF <232>/<233> and ICH Q3D
Nitrosamines Study (Phase 2)
Clinical Research Center Phase I to IV
CRO Services
Regulatory Affairs
Medical Writing
Management of Phase I to IV Studies
Clinical Monitoring
Biostatistics
Central Laboratory
Toxicology
Diagnostics
Software
About Us
Who We Are
Our Structure
Careers
Blog
EN
PT
ES
Contact Us
EN
PT
ES
Pharma
Bioequivalence Studies
Pharmaceutical Equivalence
Analytical Services
Development and validation of assays for content,
impurities and residual solvents
Solubility and dissolution for R&D
Stability study (physicochemical analysis)
Forced degradation (compliance with RDC 53/2015)
Extractables and leachables study (analysis)
Elemental impurities USP-NF <232>/<233> and ICH Q3D
Nitrosamines Study (Phase 2)
Clinical Research Center Phase I to IV
CRO Services
Regulatory Affairs
Medical Writing
Management of Phase I to IV Studies
Clinical Monitoring
Biostatistics
Central Laboratory
Toxicology
Diagnostics
Software
About Us
Who We Are
Our Structure
Careers
Blog
Pharma
Bioequivalence Studies
Pharmaceutical Equivalence
Analytical Services
Development and validation of assays for content,
impurities and residual solvents
Solubility and dissolution for R&D
Stability study (physicochemical analysis)
Forced degradation (compliance with RDC 53/2015)
Extractables and leachables study (analysis)
Elemental impurities USP-NF <232>/<233> and ICH Q3D
Nitrosamines Study (Phase 2)
Clinical Research Center Phase I to IV
CRO Services
Regulatory Affairs
Medical Writing
Management of Phase I to IV Studies
Clinical Monitoring
Biostatistics
Central Laboratory
Toxicology
Diagnostics
Software
About Us
Who We Are
Our Structure
Careers
Blog
Contact Us
Come be Synvia!
We are a dynamic and innovative company, committed to the
mission of improving the lives of more and more people.
.
We believe in the positive impact that our work generates through our teams and solutions.
That is why we continuously promote the professional development of our employees.
Our culture is guided by core values
Integrity
Leadership
Iinnovation and excellence
#ComeBeSynvia
Here, we cultivate an environment of growth and innovation.
Join our team!
Check out our open positions and apply
